About Curesponse
Curesponse is a company based in Rehovot (Israel) founded in 2018 by Guy Neev, Nancy Gavert, and Ravid Straussman. Curesponse has raised $14 million across 2 funding rounds from investors including aMoon and NCL. Curesponse offers products and services including cResponseâ„¢. Curesponse operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.
- Headquarter Rehovot, Israel
- Founders Guy Neev, Nancy Gavert, Ravid Straussman
- SectorsHealthcare
- Email••••••••
- Website curesponse.com
- Social LinkedIn YouTube
- Total Equity Funding$14M (USD)
in 2 rounds
- Latest Funding Round$8M (USD), Series B
Nov 2021
- InvestorsaMoon
& 1 more
Products & Services of Curesponse
Curesponse offers a comprehensive portfolio of products and services, including cResponse™.
Evaluates cancer therapies on biopsies for accurate treatment predictions
Apps and channels of Curesponse
its YouTube channel Curesponse has 8 subscribers.
Funding Insights of Curesponse
Curesponse has successfully raised a total of $14M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $8 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14M
- Total Rounds 2
- Last Round Series B — $8M
- First Round $6M
(Jun 2020)
- Investors Count 2
All 2 funding rounds of Curesponse with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Curesponse
Curesponse has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include aMoon and NCL.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments in healthcare are focused on by aMoon. | – | amoon.fund | - | |
- | – | nclim.co.uk | - |
Investor details for Curesponse
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Curesponse
16 people are tracked at Curesponse (6 in leadership, 7 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Guy Neev | Co-Founder & CEO | Leadership |
Nancy Gavert | Co-Founder | Leadership |
Ravid Straussman | Co-Founder | Leadership |
Gil Rosen | COO | Leadership |
Seth Salpeter | Co-Founder & CTO | Leadership |
Vered Bar | VP, Research & Development | Leadership |
Sascha Oliver Bucher | Advisor | Board & advisors |
Jonathan Krell | Advisor | Board & advisors |
Raanan Berger | Advisor | Board & advisors |
Zvika Slovin | Chair, Board of Directors | Board & advisors |
Simon Chowdhury | Advisor | Board & advisors |
Talia Golan | Advisor | Board & advisors |
Toni K. Choueiri | Advisor | Board & advisors |
Adi Zundelevich | Genomics Project Manager | Team |
Dana Laufer | Quality Assurance Manager | Team |
Dana Laufer-Sheinfeld | QA Manager | Team |
Complete people profiles for Curesponse
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Curesponse
3 dated milestones of Curesponse across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Curesponse is founded.
- Funding First funding round of $6.0M.
- Funding Latest funding round, Series B, of $8.0M.
Competitors of Curesponse
Curesponse operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. | |
| strandls.com | 2000 | Bengaluru, India | $34.88M | 532 | Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| prenetics.com | 2009 | Hong Kong, China | $67.65M | – | Health risks are identified through online genetic and diagnostic testing. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. |
Detailed competitors of Curesponse
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curesponse
Complete news archive for Curesponse
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Curesponse
10 companies that operate in the same segment as Curesponse (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Curesponse
Curesponse was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Curesponse is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
Guy Neev is the current CEO of Curesponse. They have also founded this company.
Curesponse is a funded company, having raised a total of $14M across 2 funding rounds to date. The company's 1st funding round was a Series A of $6M, raised on Jun 2020.
Founded in 2018 in Rehovot, Israel, Curesponse operates in the biotechnology sector, focusing on oncology. A proprietary tissue culture system is utilized to preserve cancer tissue, including vasculature and immune components, for studying tumor behavior in vivo. The cResponse test is offered, evaluating patient tumor samples from biopsies or surgeries against various treatments. This is integrated with genomic analysis to tailor therapies for individual cancer patients.
Curesponse's top competitors include Guardant Health, Strand Life Sciences and Sutro Biopharma.
Curesponse offers cResponseâ„¢.
Curesponse has 2 investors. Key investors include aMoon, and NCL.